ANA

(redirected from Anas)
Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

ANA

 
antinuclear antibody; American Nurses Association.

ana

 [an´ah] (Gr.)
of each, used in prescription writing; abbreviated a̿.

ANA

Abbreviation for antinuclear antibody; American Nurses Association.

ANA

American Nurses Association; antinuclear antibodies.

ana

(an´ah) [Gr.] so much of each.

ANA

abbr.
antinuclear antibody

ana

(ăn′ə)
adv.
Both in the same quantity; of each. Used to refer to ingredients in prescriptions.

ANA

1 abbreviation for American Nurses Association.
2 abbreviation for antinuclear antibody.

ana (āa, a̅a̅, A̅A̅)

See āa, a̅a̅, A̅A̅.

ANA

Abbreviation for:
acetylneuraminic acid
Acoustic Neuroma Association
alpha-naphthylacetate
American Naprapathic Association
American Narcoilepsy Association
American Neurological Association
American Nurses’ Association
American Nutritionists Association
analine nitroanilide
antinuclear antibodies (see there)
antiviral nucleoside analogue (see there)
aspartyl naphthylamide
Atlantic Nutritional Association
autoantibodies to nuclear antigens (antinuclear antibodies is preferred)

ANA

Abbreviation for antinuclear antibody
American Nurses Association.

ANA,

ANA

Abbreviation for antinuclear antibody.

ANA

antinuclear antibody.

ana

[Gr.] of each; used in prescription writing; abbreviated ā ā.
References in periodicals archive ?
Although there is no perfect assay available for screening ANAs, the COBAS-ANA is attractive as a new screening test for ANAs from the standpoints of diagnostic accuracy and effectiveness of ANA tests.
Of course, the cost for additional titration of ANAs in the IF-ANA should be multiplied, whereas the COBAS-ANA provides quantitative data.
This is an advantage for the COBAS-ANA because the ANA test is frequently requested to screen CTD patients (excluding patients with RA) from patients with RA and soft tissue rheumatism.
18), the AUC for an EIA-based ANA was not significantly different from that for an IF-ANA.
Four of these patients were positive for at least one disease-specific ANA, including one patient with RA who was positive for both anti-SSA/Ro and anti-dsDNA antibodies.
Multicenter evaluation study on a new HEp2 ANA screening enzyme Immune assay.
Hans-Peter Lehmann, David Panneton, and Syuichi Hayashi (Roche Diagnostics), Hiroshi Suno (MBL), and Tomoyoshi Terakawa (DIA-IATRON) for providing the ANA reagent sets and for helpful discussions.